Cargando…

New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues

Natural peptides show high degrees of specificity in their biological action. However, their therapeutical profile is severely limited by their conformational freedom and metabolic instability. Stapled peptides constitute a solution to these problems and access to these structures lies on a limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendive-Tapia, Lorena, Preciado, Sara, García, Jesús, Ramón, Rosario, Kielland, Nicola, Albericio, Fernando, Lavilla, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455059/
https://www.ncbi.nlm.nih.gov/pubmed/25994485
http://dx.doi.org/10.1038/ncomms8160
_version_ 1782374696592867328
author Mendive-Tapia, Lorena
Preciado, Sara
García, Jesús
Ramón, Rosario
Kielland, Nicola
Albericio, Fernando
Lavilla, Rodolfo
author_facet Mendive-Tapia, Lorena
Preciado, Sara
García, Jesús
Ramón, Rosario
Kielland, Nicola
Albericio, Fernando
Lavilla, Rodolfo
author_sort Mendive-Tapia, Lorena
collection PubMed
description Natural peptides show high degrees of specificity in their biological action. However, their therapeutical profile is severely limited by their conformational freedom and metabolic instability. Stapled peptides constitute a solution to these problems and access to these structures lies on a limited number of reactions involving the use of non-natural amino acids. Here, we describe a synthetic strategy for the preparation of unique constrained peptides featuring a covalent bond between tryptophan and phenylalanine or tyrosine residues. The preparation of such peptides is achieved in solution and on solid phase directly from the corresponding sequences having an iodo-aryl amino acid through an intramolecular palladium-catalysed C–H activation process. Moreover, complex topologies arise from the internal stapling of cyclopeptides and double intramolecular arylations within a linear peptide. Finally, as a proof of principle, we report the application to this new stapling method to relevant biologically active compounds.
format Online
Article
Text
id pubmed-4455059
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-44550592015-06-18 New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues Mendive-Tapia, Lorena Preciado, Sara García, Jesús Ramón, Rosario Kielland, Nicola Albericio, Fernando Lavilla, Rodolfo Nat Commun Article Natural peptides show high degrees of specificity in their biological action. However, their therapeutical profile is severely limited by their conformational freedom and metabolic instability. Stapled peptides constitute a solution to these problems and access to these structures lies on a limited number of reactions involving the use of non-natural amino acids. Here, we describe a synthetic strategy for the preparation of unique constrained peptides featuring a covalent bond between tryptophan and phenylalanine or tyrosine residues. The preparation of such peptides is achieved in solution and on solid phase directly from the corresponding sequences having an iodo-aryl amino acid through an intramolecular palladium-catalysed C–H activation process. Moreover, complex topologies arise from the internal stapling of cyclopeptides and double intramolecular arylations within a linear peptide. Finally, as a proof of principle, we report the application to this new stapling method to relevant biologically active compounds. Nature Pub. Group 2015-05-21 /pmc/articles/PMC4455059/ /pubmed/25994485 http://dx.doi.org/10.1038/ncomms8160 Text en Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Mendive-Tapia, Lorena
Preciado, Sara
García, Jesús
Ramón, Rosario
Kielland, Nicola
Albericio, Fernando
Lavilla, Rodolfo
New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
title New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
title_full New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
title_fullStr New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
title_full_unstemmed New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
title_short New peptide architectures through C–H activation stapling between tryptophan–phenylalanine/tyrosine residues
title_sort new peptide architectures through c–h activation stapling between tryptophan–phenylalanine/tyrosine residues
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455059/
https://www.ncbi.nlm.nih.gov/pubmed/25994485
http://dx.doi.org/10.1038/ncomms8160
work_keys_str_mv AT mendivetapialorena newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues
AT preciadosara newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues
AT garciajesus newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues
AT ramonrosario newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues
AT kiellandnicola newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues
AT albericiofernando newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues
AT lavillarodolfo newpeptidearchitecturesthroughchactivationstaplingbetweentryptophanphenylalaninetyrosineresidues